Related Experiment Video
Updated: Mar 4, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Complications of chronic necrotizing pulmonary aspergillosis: review of published case reports
Aleksandra Barac1, Tatjana Adzic Vukicevic2,3, Aleksandra Dudvarski Ilic2,3
1Clinical Centre of Serbia, Clinic for Infectious and Tropic Diseases, Belgrade, Serbia.
Abstract:
Chronic necrotizing pulmonary aspergillosis (CNPA), a form of chronic pulmonary aspergillosis (CPA), affects immunocompetent or mildly immunocompromised persons with underlying pulmonary disease. These conditions are associated with high morbidity and mortality and often require long-term antifungal treatment. The long-term prognosis for patients with CNPA and the potential complications of CNPA have not been well documented. The aim of this study was to review published papers that report cases of CNPA complications and to highlight risk factors for development of CNPA. The complications in conjunction associated with CNPA are as follows: pseudomembranous necrotizing tracheobronchial aspergillosis, ankylosing spondylarthritis, pulmonary silicosis, acute respiratory distress syndrome, pulmonary Mycobacterium avium complex (MAC) disease, superinfection with Mycobacterium tuberculosis, and and pneumothorax. The diagnosis of CNPA is still a challenge. Culture and histologic examinations of bronchoscopically identified tracheobronchial mucus plugs and necrotic material should be performed in all immunocompromised individuals, even when the radiographic findings are unchanged. Early detection of intraluminal growth of Aspergillus and prompt antifungal therapy may facilitate the management of these patients and prevent development of complications.
Insights
Chronic necrotizing pulmonary aspergillosis (CNPA) can lead to serious complications. Early diagnosis and antifungal treatment are crucial for managing this fungal lung infection and improving patient outcomes.
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Chronic necrotizing pulmonary aspergillosis (CNPA) is a severe form of chronic pulmonary aspergillosis (CPA).
- It primarily affects individuals with underlying lung conditions, even those with competent or mildly compromised immune systems.
- CNPA is linked to significant morbidity and mortality, often necessitating prolonged antifungal interventions.
Purpose of the Study:
- To review documented complications associated with CNPA.
- To identify risk factors contributing to the development of CNPA.
- To enhance understanding of the long-term prognosis and potential sequelae of CNPA.
Main Methods:
- Systematic review of published literature reporting cases of CNPA complications.
- Analysis of identified cases to highlight associated risk factors and clinical presentations.
Main Results:
- CNPA complications include pseudomembranous necrotizing tracheobronchial aspergillosis, ankylosing spondylarthritis, pulmonary silicosis, ARDS, MAC disease, tuberculosis superinfection, and pneumothorax.
- Diagnosis of CNPA remains challenging, often requiring bronchoscopic examination of mucus plugs and necrotic material.
- Radiographic stability does not exclude CNPA in immunocompromised patients.
Conclusions:
- Prompt diagnosis and treatment of Aspergillus intraluminal growth are vital.
- Early antifungal therapy can aid in managing CNPA and preventing severe complications.
- Further research is needed to fully elucidate the long-term prognosis and management strategies for CNPA.
More Related Videos
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
08:01Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment
Asthma-III: Symptoms and Complications
Classification of Asthma
Rheumatic Heart Disease I: Introduction
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...